Population Pharmacokinetics of Anidulafungin in Critically Ill Patients

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00378-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacokinetics of Anidulafungin in Critically Ill Patients With Candida Peritonitis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

Clinical Drug Investigation
MedicinePharmacology
2013English

Limited-Sampling Strategies for Anidulafungin in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Pharmacokinetics of Micafungin in Critically Ill Patients

Scientific Reports
Multidisciplinary
2019English

Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Critically Ill and Non-Critically Ill AIDS Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Altered Pharmacokinetics of Ceftazidime in Critically Ill Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Clinical Pharmacokinetics
Pharmacology
2008English

Population Pharmacokinetics of Total and Unbound Concentrations of Intravenous Posaconazole in Adult Critically Ill Patients

Critical Care
Critical CareIntensive Care Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy